Acetobromo-a-D-glucuronic acid methyl ester, 95.0%, 5g

tert-Butyl 3-(((benzyloxy)carbonyl)amino)propanoate, 95.0%, 5g

((2S,7aR)-2-Fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl)methanol, 97%, 250mg

2,4-Dimethyl-4-hydroxymethyl-2-oxazoline, 10g

(R)-2-Amino-3-(1-(tert-butoxycarbonyl)-1H-indol-3-yl)propanoic acid, 95.0%, 1g

DMT-dG(ib) Phosphoramidite, 5g

Seals with hole, GL 25, 8 mm, 2 Piece(s)

1-[(3aS,8aS)-tetrahydro-2,2-diMethyl-4,4,8,8-tetraphenyl-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl]- Piperidine, 98%, 250mg

3-(2-Fluoro-4-(trifluoromethyl)phenyl)acrylic acid, 97%, 5g

Potassium Carbonate>99.0%(T)300g

1-(4-Hydroxypiperidin-1-yl)-2-phenylethan-1-one, 98%, 1g

GC capillary column ROTI®Cap-1, 50 m, 0.20 mm, 0.50 µm, 1 Piece(s)

tert-Butyl 5-(hydroxymethyl)indoline-1-carboxylate, 98%, 100mg